BlueRock Therapeutics Compagnie réclamée
BlueRock Therapeutics LP is a clinical stage cell therapy harnessing the power of cell therapy to create a pipeline of new medicines for people suffering from neurological and ophthalmic diseases. Two of our novel investigational cell therapies, bemdaneprocel (BRT-DA01) for the treatment of Parkinson’s disease and OpCT-001 for the treatment of primary photoreceptor diseases are clinical stage programs. BlueRock was founded in 2016 as a joint venture of Versant Ventures and Leaps by Bayer. Our culture is defined by the courage to persist regardless of the challenge, the urgency to transform medicine and deliver hope, integrity guided by mission, and community-mindedness with the understanding that we are all part of something bigger than ourselves.
Lire la suite
BlueRock has an incredible pool of talented, driven and friendly employees, which makes working here challenging and satisfying. Navigating the Bayer relationship adds complexities, but seems to be manageable so far.
Quelle est la meilleure partie de votre programme de rémunération?
Nothing stands out, but it is competitive with industry norms.
Qu’est-ce qui vous rend le plus heureux au travail?
Interacting with such talented colleagues and learning something new every day.
Quelles sont les meilleures choses à propos de votre équipe?
Passion for the work and respect for others; willingness to learn constantly.
Qu’est-ce qui est le plus positif à propos de la culture et de l’environnement de votre entreprise?
The commitment to hire not just incredible talent and SMEs, but also the right personality.
Qu’est-ce qui vous plaît le plus dans l’équipe de direction?
Ability to listen and truly consider what they heard; focus, energy, drive, yet still with an eye on a good corporate culture.
Other Employee Reviews for BlueRock Therapeutics
×